These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 33808256)

  • 21. Infectious Progression of Canine Distemper Virus from Circulating Cerebrospinal Fluid into the Central Nervous System.
    Takenaka A; Sato H; Ikeda F; Yoneda M; Kai C
    J Virol; 2016 Oct; 90(20):9285-92. PubMed ID: 27489268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum.
    Muñoz-Alía MÁ; Nace RA; Tischer A; Zhang L; Bah ES; Auton M; Russell SJ
    PLoS Pathog; 2021 Feb; 17(2):e1009283. PubMed ID: 33534834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viral oncolysis - can insights from measles be transferred to canine distemper virus?
    Lapp S; Pfankuche VM; Baumgärtner W; Puff C
    Viruses; 2014 Jun; 6(6):2340-75. PubMed ID: 24921409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Delivered by Canine Histiocytic Sarcoma Cells Persistently Infected with Engineered Attenuated Canine Distemper Virus.
    Marek K; Armando F; Asawapattanakul T; Nippold VM; Plattet P; Gerold G; Baumgärtner W; Puff C
    Pathogens; 2023 Jun; 12(7):. PubMed ID: 37513724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant rabies virus expressing the H protein of canine distemper virus protects dogs from the lethal distemper challenge.
    Wang FX; Zhang SQ; Zhu HW; Yang Y; Sun N; Tan B; Li ZG; Cheng SP; Fu ZF; Wen YJ
    Vet Microbiol; 2014 Dec; 174(3-4):362-371. PubMed ID: 25465178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment.
    Koske I; Rössler A; Pipperger L; Petersson M; Barnstorf I; Kimpel J; Tripp CH; Stoitzner P; Bánki Z; von Laer D
    Int J Cancer; 2019 Oct; 145(7):1958-1969. PubMed ID: 30972741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis of canine distemper virus in experimentally infected raccoon dogs, foxes, and minks.
    Zhao J; Shi N; Sun Y; Martella V; Nikolin V; Zhu C; Zhang H; Hu B; Bai X; Yan X
    Antiviral Res; 2015 Oct; 122():1-11. PubMed ID: 26210812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivated Recombinant Rabies Viruses Displaying Canine Distemper Virus Glycoproteins Induce Protective Immunity against Both Pathogens.
    da Fontoura Budaszewski R; Hudacek A; Sawatsky B; Krämer B; Yin X; Schnell MJ; von Messling V
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsies.
    Autio K; Knuuttila A; Kipar A; Ahonen M; Parviainen S; Diaconu I; Kanerva A; Hakonen T; Vähä-Koskela M; Hemminki A
    Vet Comp Oncol; 2016 Dec; 14(4):395-408. PubMed ID: 25302859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper.
    Wang X; Feng N; Ge J; Shuai L; Peng L; Gao Y; Yang S; Xia X; Bu Z
    Vaccine; 2012 Jul; 30(34):5067-72. PubMed ID: 22698451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel canine histiocytic sarcoma cell line: initial characterization and utilization for drug screening studies.
    Takada M; Parys M; Gregory-Bryson E; Vilar Saavedra P; Kiupel M; Yuzbasiyan-Gurkan V
    BMC Cancer; 2018 Mar; 18(1):237. PubMed ID: 29490634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization and evaluation of a new oncolytic vaccinia virus strain LIVP6.1.1 for canine cancer therapy.
    Gentschev I; Patil SS; Adelfinger M; Weibel S; Geissinger U; Frentzen A; Chen NG; Yu YA; Zhang Q; Ogilvie G; Szalay AA
    Bioengineered; 2013; 4(2):84-9. PubMed ID: 23093804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of two recent Japanese field isolates of canine distemper virus and examination of the avirulent strain utility as an attenuated vaccine.
    Takenaka A; Yoneda M; Seki T; Uema M; Kooriyama T; Nishi T; Fujita K; Miura R; Tsukiyama-Kohara K; Sato H; Kai C
    Vet Microbiol; 2014 Dec; 174(3-4):372-381. PubMed ID: 25465179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and characterization of neutralizing monoclonal antibodies against canine distemper virus hemagglutinin protein.
    Bi Z; Xia X; Wang Y; Mei Y
    Microbiol Immunol; 2015 Apr; 59(4):202-8. PubMed ID: 25644427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dog lymphocyte cultures facilitate the isolation and growth of virulent canine distemper virus.
    Appel MJ; Pearce-Kelling S; Summers BA
    J Vet Diagn Invest; 1992 Jul; 4(3):258-63. PubMed ID: 1387554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor activity of an oncolytic measles virus against canine urinary bladder transitional cell carcinoma cells.
    Iizuka K; Shoji K; Fujiyuki T; Moritoh K; Tamura K; Yoshida A; Sato H; Yoneda M; Asano K; Kai C
    Res Vet Sci; 2020 Dec; 133():313-317. PubMed ID: 33183781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SLAM- and nectin-4-independent noncytolytic spread of canine distemper virus in astrocytes.
    Alves L; Khosravi M; Avila M; Ader-Ebert N; Bringolf F; Zurbriggen A; Vandevelde M; Plattet P
    J Virol; 2015 May; 89(10):5724-33. PubMed ID: 25787275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canine distemper virus induces apoptosis through caspase-3 and -8 activation in vero cells.
    Kajita M; Katayama H; Murata T; Kai C; Hori M; Ozaki H
    J Vet Med B Infect Dis Vet Public Health; 2006 Aug; 53(6):273-7. PubMed ID: 16907958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncolytic Activity of Canine Distemper Virus in Human Ductal Breast Carcinoma Cells.
    Jhala D; Nathani N; Joshi M; Patel A; Joshi CG
    Oncol Res Treat; 2024; 47(1-2):10-17. PubMed ID: 38008084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent.
    Gentschev I; Stritzker J; Hofmann E; Weibel S; Yu YA; Chen N; Zhang Q; Bullerdiek J; Nolte I; Szalay AA
    Cancer Gene Ther; 2009 Apr; 16(4):320-8. PubMed ID: 18949014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.